About LabGenomics
LabGenomics is a publicly listed company based in Seongnam, South Korea. LabGenomics is engaged in molecular diagnostics and personalized healthcare solutions. It operates on a HealthTech model. LabGenomics has completed 1 acquisition, including QDx Pathology Services. LabGenomics offers products and services including Molecular Diagnostic Testing, Personal Genetic Testing, and Personal Microbiome Testing. Its focus areas include Diagnostics and Molecular Diagnostics.
Company details
LabGenomics is focused on molecular diagnostics and personalized healthcare solutions. The company is involved in providing genetic and microbiome testing services for individuals, ranging from prenatal to neonatal care. Operations are centered in the healthcare sector, with an emphasis on innovative diagnostic technologies. Services are extended globally, aiming to enhance health management through advanced medical technologies. Collaboration with international partners is pursued to expand diagnostic capabilities and introduce cutting-edge solutions.
- Headquarters Seongnam, South Korea
- Stage Public
- SectorsHealthcare
- Phone•••• ••••
- Website labgenomics.co.kr
- Social LinkedIn YouTube
- Legal Name Labgenomics Co., Ltd.
- Annual Revenue$61.04 M (USD)2.63as on Dec 31, 2025
- Net Profit-$44.57 M (USD)-170.53as on Dec 31, 2025
- EBITDA-$30.89 M (USD)-401.68as on Dec 31, 2025
- Investments & Acquisitions
Products & Services of LabGenomics
LabGenomics offers a comprehensive portfolio of products and services, including Molecular Diagnostic Testing, Personal Genetic Testing, and Personal Microbiome Testing.
Molecular testing for personalized health management is provided.
Genetic traits are analyzed for personal health improvement.
Microbiome analysis for oral and vaginal health is offered.
Apps and channels of LabGenomics
its YouTube channel LabGenomics 랩지노믹스 has 248 subscribers and 15 videos.
Videos from LabGenomics
The most watched videos on LabGenomics's YouTube channel, LabGenomics 랩지노믹스 (248 subscribers). Click a video to play it here.
More on LabGenomics 랩지노믹스.
IPO & Listings of LabGenomics
LabGenomics is a publicly listed company on the KRX with ticker symbol 084650 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date01 Jul 2013
- Listed onKRX: 084650
- Listed entityLabGenomics Co., Ltd.
- Exchange sectorHealth technology
- ISINKR7084650001
- Share price2,445.00 KRW (-2.2% on the day) · 2026-10-14
- Market capitalisation37,119,994,164.00 KRW
- EPS (diluted, trailing year)-3,474.90 KRW
- Volume (last session)25,239
Financials of LabGenomics
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 88.16B KRW | -64.37B KRW | -44.61B KRW |
| 2024 | 85.90B KRW | -23.80B KRW | -8.89B KRW |
| 2023 | 71.08B KRW | -4.67B KRW | -1.03B KRW |
| 2022 | 144.77B KRW | 48.40B KRW | 70.05B KRW |
| 2021 | 202.41B KRW | 83.85B KRW | 107.41B KRW |
Detailed financial statements for LabGenomics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by LabGenomics
LabGenomics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include QDx Pathology Services.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Full-service molecular and anatomical pathology services are offered. | qdxpath.com | Cranford, United States | 2006 | Sep 2023 | •••• |
Complete acquisition details for LabGenomics
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about LabGenomics
Annual revenue of LabGenomics is $61.04M as on Dec 31, 2025.
LabGenomics is focused on molecular diagnostics and personalized healthcare solutions. The company is involved in providing genetic and microbiome testing services for individuals, ranging from prenatal to neonatal care. Operations are centered in the healthcare sector, with an emphasis on innovative diagnostic technologies. Services are extended globally, aiming to enhance health management through advanced medical technologies. Collaboration with international partners is pursued to expand diagnostic capabilities and introduce cutting-edge solutions.
LabGenomics offers Molecular Diagnostic Testing, Personal Genetic Testing, and Personal Microbiome Testing.
Yes, LabGenomics is publicly traded on KRX under the ticker symbol 084650.
LabGenomics has made 1 acquisition, including QDx Pathology Services.